Lacosamide, Urine Test (2527U)
| Analysis Code |
2527U |
| Test Name |
Lacosamide, Urine |
| Test Includes |
Lacosamide |
| Compound Synonym(s) |
Vimpat® |
| Purpose |
Therapeutic Drug Monitoring; This test is New York State approved. |
| Category |
Anticonvulsant |
| Method(s) |
High Performance Liquid Chromatography/ Tandem Mass Spectrometry (LC-MS/MS) |
| Specimen Requirements |
2 mL Urine |
| Transport Temperature |
Refrigerated |
| Specimen Container |
Plastic container (preservative-free) |
| Special Handling |
None |
| Light Protection Required |
Not Required |
| Stability |
Room Temperature: 15 day(s)
Refrigerated: 15 day(s)
Frozen (-20 °C): 15 day(s) |
| *Rejection Criteria |
None |
| Day(s) Test Set-up / TAT |
[LC-MS/MS] Monday Thursday / 3 days |
| Suggested CPT Code |
80339 |
| **Minimum Volume |
0.615 mL |
| Test Summary Sheet |
Generate
|
You are viewing Lacosamide, Urine Test (2527U)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.